69
Participants
Start Date
October 24, 2012
Primary Completion Date
September 8, 2019
Study Completion Date
September 8, 2019
Pazopanib
800 mg by mouth daily in 4 week study cycle.
Temsirolimus
25 mg by vein infused over 30-60 minutes every week in 4 week study cycle.
Quality of Life Assessment
Completion of full assessment battery at baseline, prior to treatment then every 8 weeks at clinical evaluation.
Benadryl
25 to 50 mg by vein approximately 30 minutes before the start of each dose of temsirolimus.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Novartis
INDUSTRY
M.D. Anderson Cancer Center
OTHER